Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSBP Foundation, Inc.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
217 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ciusss de L'Est-de-L'Ile-de-Montreal-Hopital-Maisonneuve-Rosemont
Montreal, Quebec, Canada
- Centre Hospitalier D'Universite de Montreal Chum-Hotel Dieu
Montreal, Quebec, Canada
- Mcgill University Health Centre-Cedars Cancer Centre
Montreal, Quebec, Canada
- Smbd-Jewish General Hospital (mpsg)
Montreal, Quebec, Canada
- Chu de Quebec-Hospital Du Saint-Sacrement
Québec, Quebec, Canada
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- St. Bernard'S Medical Center
Jonesboro, Arkansas, United States
- St. Bernard'S Medical Center
Paragould, Arkansas, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Arrowhead Regional Medical Center
Colton, California, United States
- City of Hope
Duarte, California, United States
- Kaiser Permanente-Fontana
Fontana, California, United States
- Kaiser Permanente-Harbor City
Harbor City, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Cancer and Blood Specialty Clinic
Los Alamitos, California, United States
- Kaiser Permanente-Sunset
Los Angeles, California, United States
- Kaiser Permanente-West Los Angeles
Los Angeles, California, United States
- Kaiser Permanente-Panorama City
Panorama City, California, United States
- Kaiser Permanente-Riverside
Riverside, California, United States
- Kaiser Permanente - Otay
San Diego, California, United States
- Kaiser Permanente Medical Group
San Diego, California, United States
- Kaiser Permanente-Zion
San Diego, California, United States
- Kaiser Permanente- San Marcos
San Marcos, California, United States
- City of Hope - South Pasadena
South Pasadena, California, United States
- Torrance Memorial Physician Network
Torrance, California, United States
- City of Hope - Upland
Upland, California, United States
- Pih Health
Whittier, California, United States
- Kaiser Permanente-Woodland Hills
Woodland Hills, California, United States
- Mount Sinai Comprehensive Cancer Center Aventura
Aventura, Florida, United States
- Memorial Healthcare System Office of Human Research
Hollywood, Florida, United States
- Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, United States
- Uf Health Cancer Center at Orlando Health
Orlando, Florida, United States
- Gwinnett Hospital System Center for Cancer Care
Duluth, Georgia, United States
- Gwinnett Hospital System Center for Cancer Care
Lawrenceville, Georgia, United States
- Gwinnett Hospital System Center for Cancer Care
Snellville, Georgia, United States
- Illinois Cancer Care-Bloomington
Bloomington, Illinois, United States
- John H. Stroger, Jr. Hospital of Cook County
Chicago, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Dec 2017
- Primary completion
- 31 Dec 2024
- Completion
- 30 Nov 2027
- Last update posted
- 8 Apr 2024
- Registered enrollment
- 1,550
- Registry id
- NCT03281954
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.